Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held by Syndax Pharmaceuticals, Inc. on May 17, 2017. The filing details the voting outcomes for director elections and the ratification of the independent auditor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is a corporate governance report regarding shareholder voting results.
Material Changes
There are no material financial changes reported in this document. The primary events are the successful election of two directors and the ratification of the accounting firm.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on operations, risk factors, or contingencies. It strictly reports the historical voting results from the May 17, 2017 meeting.
Key Facts for Investor Verification
- Director Elections: Stockholders elected Fabrice Egros and Pierre Legault to serve three-year terms until the 2020 Annual Meeting.
- Voting Results for Fabrice Egros: 10,768,003 votes For, 561,937 votes Withheld, and 882,338 Broker Non-Votes.
- Voting Results for Pierre Legault: 11,242,559 votes For, 87,381 votes Withheld, and 882,338 Broker Non-Votes.
- Auditor Ratification: Stockholders ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2017.
- Auditor Voting Results: 12,183,958 votes For, 28,145 votes Against, and 175 votes Abstain.